Single-Cut Gene Editing Therapy for Duchenne Muscular Dystrophy via a Single AAV Vector

被引：0
|
作者：
Li, Guoling [1 ]
Lin, Jiajia [2 ]
Li, Haisen [1 ]
Jin, Ming [2 ]
Li, Zhifang [3 ]
Shi, Linyu [1 ]
Wang, Ning [2 ]
Chen, Wanjin [2 ]
Yang, Hui [1 ,4 ]
机构：
[1] HuidaGene Therapeut Co Ltd, Shanghai, Peoples R China
[2] Fujian Med Univ, Affiliated Hosp 1, Dept Neurol, Fuzhou, Peoples R China
[3] Lingang Lab, Shanghai, Peoples R China
[4] Chinese Acad Sci, Ctr Excellence Brain Sci & Intelligence Technol, Shanghai, Peoples R China
来源：
MOLECULAR THERAPY | 2023年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
951
引用
收藏
页码：461 / 462
页数：2
相关论文
共 50 条
  • [31] A Novel AAV8 Vector for Microdystrophin Gene Therapy of Duchenne Muscular Dystrophy: Preclinical Studies in the Mdx Mouse
    Kim, SunJung
    Buss, Nicholas
    Patel, Hiren
    Yang, Lin
    Elliott, Kirk
    Qiao, Chunping
    Liu, Ye
    Fiscella, Michele
    Danos, Olivier
    MOLECULAR THERAPY, 2021, 29 (04) : 297 - 298
  • [32] AAV gene therapy for Duchenne muscular dystrophy: the EMBARK phase 3 randomized trial
    Mendell, Jerry R.
    Muntoni, Francesco
    Mcdonald, Craig M.
    Mercuri, Eugenio M.
    Ciafaloni, Emma
    Komaki, Hirofumi
    Leon-Astudillo, Carmen
    Nascimento, Andres
    Proud, Crystal
    Schara-Schmidt, Ulrike
    Veerapandiyan, Aravindhan
    Zaidman, Craig M.
    Guridi, Maitea
    Murphy, Alexander P.
    Reid, Carol
    Wandel, Christoph
    Asher, Damon R.
    Darton, Eddie
    Mason, Stefanie
    Potter, Rachael A.
    Singh, Teji
    Zhang, Wenfei
    Fontoura, Paulo
    Elkins, Jacob S.
    Rodino-Klapac, Louise R.
    NATURE MEDICINE, 2025, 31 (01) : 332 - 341
  • [33] The gRNA Vector Level Determines the Outcome of Systemic AAV CRISPR Therapy for Duchenne Muscular Dystrophy
    Morales, Emily
    Wasala, Nalinda
    Watkins, Thais
    Wasala, Lakmini
    Han, Jin
    Yue, Yongping
    Lu, Baisong
    Chen, Shi-Jie
    Hakim, Chady
    Duan, Dongsheng
    MOLECULAR THERAPY, 2022, 30 (04) : 497 - 497
  • [34] The gRNA Vector Level Determines the Outcome of Systemic AAV CRISPR Therapy for Duchenne Muscular Dystrophy
    Wasala, Nalinda B.
    Million, Emily D.
    Watkins, Thais B.
    Wasala, Lakmini P.
    Han, Jin
    Yue, Yongping
    Lu, Baisong
    Chen, Shi-jie
    Hakim, Chady H.
    Duan, Dongsheng
    HUMAN GENE THERAPY, 2022, 33 (9-10) : 518 - 528
  • [35] Single Systemic AAV Micro-Dystrophin Therapy Ameliorates Muscular Dystrophy in Young Adult Duchenne Muscular Dystrophy Dogs for Up to Two Years
    Hakim, Chady H.
    Kodippili, Kasun
    Jenkins, Gregory
    Yang, Hsiao T.
    Pan, Xiufang
    Lessa, Thais B.
    Leach, Stacey B.
    Emter, Craig
    Yue, Yongping
    Zhang, Keqing
    Duan, Sean
    Yao, Gang
    Schneider, Joel S.
    Yang, Nora N.
    Chamberlain, Jeffrey S.
    Duan, Dongsheng
    MOLECULAR THERAPY, 2017, 25 (05) : 192 - 193
  • [36] Development of Adenoviral Vectors for the Treatment of Duchenne Muscular Dystrophy with One Single Vector
    Ehrke-Schulz, Eric
    van den Boom, Alexander
    Zhang, Wenli
    Ehrhardt, Anja
    MOLECULAR THERAPY, 2019, 27 (04) : 102 - 102
  • [37] Advances in Duchenne muscular dystrophy gene therapy
    Judith C. T. van Deutekom
    Gert-Jan B. van Ommen
    Nature Reviews Genetics, 2003, 4 : 774 - 783
  • [38] RESEARCHERS TEST GENE EDITING STRATEGY FOR DUCHENNE MUSCULAR DYSTROPHY
    不详
    CIRCULATION, 2020, 142 (01) : 85 - 85
  • [39] Duchenne muscular dystrophy awaits gene therapy
    Dan Jones
    Nature Biotechnology, 2019, 37 : 335 - 337
  • [40] Duchenne muscular dystrophy awaits gene therapy
    Jones, Dan
    NATURE BIOTECHNOLOGY, 2019, 37 (04) : 335 - 337
12345